But you can guarantee if govt regulated as such costs would be passed on to patients and the healthcare systems. If anything pharma would blame regulation and take it as an opportunity for some friendly gouging.
Versus listen to the market complain about compliance issues with their devices...you only have to look at the case study I posted a few years ago about Lovenox and when it first moved to a syringe guard and how they stole market share which others never were able to really recover. Industry needs to do this on their own otherwise other people end up shoring up their businesses vs pharma investing in their own businesses. Stuff em!
History has shown early adopters of sound, cost effective technology yield benefits. Nobody seems brave enough to take that plunge with Unifill and are seemingly just going to the proven disposable Autoinjector. But whilst none are taking the plunge, the likes of Hikma and Sanofi are slowly looking to Unifill and seeminglt have plans in place to roll them out....just not the whole shop, just a shelf
UNS Price at posting:
14.0¢ Sentiment: Hold Disclosure: Held
